0001209191-20-052113.txt : 20200925
0001209191-20-052113.hdr.sgml : 20200925
20200925171125
ACCESSION NUMBER: 0001209191-20-052113
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200923
FILED AS OF DATE: 20200925
DATE AS OF CHANGE: 20200925
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Manning Paul B
CENTRAL INDEX KEY: 0001494695
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39536
FILM NUMBER: 201200927
MAIL ADDRESS:
STREET 1: 200 GARRETT STREET SUITE S
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Taysha Gene Therapies, Inc.
CENTRAL INDEX KEY: 0001806310
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 843199512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7318 MORTON STREET
CITY: DALLAS
STATE: TX
ZIP: 75209
BUSINESS PHONE: 212.551.8702
MAIL ADDRESS:
STREET 1: 7318 MORTON STREET
CITY: DALLAS
STATE: TX
ZIP: 75209
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-23
0
0001806310
Taysha Gene Therapies, Inc.
TSHA
0001494695
Manning Paul B
C/O TAYSHA GENE THERAPIES, INC.
2280 INWOOD ROAD
DALLAS
TX
75235
1
0
1
0
Stock Option (right to buy)
20.00
2020-09-23
4
A
0
31000
0.00
A
2030-09-23
Common Stock
31000
31000
D
The shares subject to the Option vest in 36 equal monthly installments, subject to the Reporting Person continuing to provide service through each such date.
/s/ Kamran Alam, Attorney-in-Fact
2020-09-25